Health Policy
WHO guidelines, EU directives, and Georgian health governance
Biotech Industry Faces Political Uncertainty and AI Profitability Questions at BIO 2026
Biotech executives at BIO 2026 confronted mounting concerns over Chinese competition, the uncertain profitability of AI-driven drug discovery, and political…
Editor's Top Picks
Eli Lilly’s Obesity Drug Access: What We Know About FDA Approval Pathways
Regulatory pathways and corporate strategy shape early access to obesity drug candidates. Pharmaceutical acquisitions in the metabolic disease sector reflect…
Submit Your Paper →
More form Health Policy
Cancer drug shortages force US hospitals to ration chemotherapy as supply crisis deepens
US oncology departments face critical shortages of essential generic chemotherapy drugs, forcing some hospitals to…
NHS Emergency Department HIV Testing Identifies 1,953 Previously Undiagnosed Cases Over Four Years
A pioneering NHS programme testing all patients requiring blood draws in emergency departments across 88…
Hospital-Acquired Infections Rising in UK: Latest Surveillance Data Shows Increases in Dangerous Pathogens
New UK Health Security Agency surveillance data for Q1 2026 reveal trends in hospital-acquired infections,…
US 988 Crisis Line Relaunches LGBTQ+ Hotline Without Original Founding Partner
The Trump administration is relaunching a specialized LGBTQ+ crisis line option under the US 988…
Burundi’s first quarter 2026: refugees access care as WHO strengthens health partnerships
WHO's first-quarter 2026 report documents that over 65,000 Congolese refugees in Burundi accessed healthcare through…